Clinical trials
Stomach Neoplasms trials in Sweden
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
32 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2003 | 1 |
| 2005 | 1 |
| 2009 | 1 |
| 2012 | 1 |
| 2014 | 2 |
| 2015 | 3 |
| 2016 | 1 |
| 2017 | 1 |
| 2019 | 1 |
| 2020 | 4 |
| 2021 | 2 |
| 2022 | 3 |
| 2023 | 3 |
| 2024 | 3 |
| 2025 | 1 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 13 |
| Recruiting | 6 |
| Not yet recruiting | 4 |
| Terminated | 4 |
| Active, not recruiting | 3 |
| Unknown status | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Karolinska Institutet | 4 |
| Region Skane | 3 |
| Amgen | 2 |
| Region Stockholm | 2 |
| St. James's Hospital, Ireland | 2 |
| BioNTech Cell & Gene Therapies GmbH | 1 |
| Eli Lilly and Company | 1 |
| European Organisation for Research and Treatment of Cancer - EORTC | 1 |
| Fredrik Klevebro | 1 |
| GE Healthcare | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Stomach Neoplasms | 32 |
| Esophageal Neoplasms | 12 |
| Colorectal Neoplasms | 4 |
| Pancreatic Neoplasms | 4 |
| Carcinoma, Non-Small-Cell Lung | 3 |
| Ovarian Neoplasms | 3 |
| Weight Loss | 3 |
| Endometrial Neoplasms | 2 |
| Malnutrition | 2 |
| Peritoneal Neoplasms | 2 |
Trials
Showing 1 to 25 of 32. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.